Short answer

Recurrent vaginal symptoms are diagnostic problems demanding escalation, not repetition: after two or three cycles of the same complaint, the right move is deeper investigation. Cultures with susceptibilities, STI retesting including trichomoniasis and M.

genitalium specifics, vulvar dermatology with biopsy thresholds, and reinfection-loop audits. Rather than another round of the same prescription.

Repetition without re-evaluation is the definition of the cycle patients get stuck in for months.

Advertisement

Sponsored: confidential STD testing with results in 1–2 days

Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.

See Tests & Prices →

Escalation workup, test by test

  • Yeast cultures with species and susceptibility (not just microscopy). Non-albicans species need different antifungals, and recurrent cases deserve identification, not assumption.
  • NAAT retesting for trichomoniasis, chlamydia/gonorrhea, and M. genitalium. Uncovered organisms explain many “treatment-resistant” cases.
  • BV Nugent scoring and pH/amine baselines quantify what symptoms describe vaguely.
  • Vulvar examination with biopsy for skin changes. Lichen disorders can’t be diagnosed by discharge assessment.
  • Diabetes and hormonal reviews. Glucose/HbA1c for recurrent yeast, contraceptive and menopausal contributors for dryness patterns.

Reinfection loops: the commonest answer

Partner treatment verification (were they actually treated, or just told?), abstinence-window compliance, new-exposure timelines since therapy, and condom-pattern audits.

Most “treatment-resistant” cases resolve to network gaps on careful history. Simultaneous partner therapy plus verified abstinence breaks cycles that prescriptions alone never will.

See Preventing STI Reinfection After Treatment.

Dermatosis pathway: the under-recognized answer

  • Lichen sclerosus and planus need long-term management (potent topical steroids, irritant elimination, sometimes estrogen) under gynecologic or dermatologic co-care. And biopsy for diagnosis.
  • Chronic contact dermatitis resolves with irritant identification, not stronger antifungals.
  • Atrophic changes respond to moisturizers and hormonal options.

None of these improve with repeated antibiotics or antifungals, which is precisely how months get lost.

Diary-driven diagnosis that works

Track cycle timing (hormonal patterns), products used (irritant patterns), sexual activity and protection (reinfection patterns), treatments taken with responses (resistance patterns), and symptom photos or descriptions.

Cycle-correlated points hormonal; product-correlated points irritant; partner-correlated points reinfection/STI; treatment-response patterns point to resistance or misdiagnosis.

Bring the diary. Tracked data outperforms recall at every visit.

When to seek care

After two or three recurrences request an escalation visit explicitly (not a repeat prescription), with skin changes advocate for biopsy rather than another cream, and for diary-reviewed comprehensive reassessment that treats the pattern, not the episode.